Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To examine whether, after 24 weeks of oral administration of double-blind treatment, the change from baseline in glycosylated haemoglobin A1c (HbA1c) level with dapagliflozin 10 mg plus metformin is non-inferior to sitagliptin (DPP-4 inhibitor) 100 mg plus metformin in patients with type 2 diabetes who have inadequate glycaemic control on 1500 mg/day or higher doses of metformin therapy alone.
Critère d'inclusion
- Type 2 diabetes mellitus